|
Market Closed -
NYSE
04:00:02 2026-10-19 pm EDT
|
5-day change | 1st Jan Change | ||
| 118.73 USD | +0.38% |
|
+0.03% | +48.13% |
| Oct. 19 | Haemonetics Gets FDA Approval for Vascular Closure Device | DJ |
| Oct. 19 | Haemonetics says FDA clears vascular closure device | RE |
| Market Cap | 5.38B 4.8B 4.45B 4.04B 7.59B 511B 7.71B 53.34B 20.95B 267B 20.19B 19.77B 853B | P/E 2027 * |
29.8x | P/E 2028 * | 26.2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.04B 5.39B 5B 4.54B 8.52B 574B 8.66B 59.9B 23.53B 300B 22.68B 22.2B 958B | EV / Sales 2027 * |
4.27x | EV / Sales 2028 * | 3.82x |
| Free-Float |
98.74% | Yield 2027 * |
0.85% | Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| HAE | Delayed | |
CBOE
| HAE | Real-time | |
|
Tradegate
| HAZ | Real-time | |
|
Boerse Muenchen
| HAZ | Real-time | |
|
Deutsche Boerse AG
| HAZ | Delayed | |
|
Börse Stuttgart
| HAZ | Delayed |
Last Transcript: Haemonetics Corporation
| 1 day | +0.38% | ||
| 1 week | +0.03% | ||
| Current month | +12.75% | ||
| 1 month | +9.53% | ||
| 3 months | +52.49% | ||
| 6 months | +92.68% | ||
| Current year | +48.13% |
| 1 week | 117 |  | 123.77 |
| 1 month | 101.32 | | 123.77 |
| Current year | 51 | | 123.77 |
| 1 year | 48.98 | | 123.77 |
| 3 years | 47.32 | | 123.77 |
| 5 years | 43.5 | | 123.77 |
| 10 years | 32.76 | | 142.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 2016-05-15 | |
James D'Arecca
DFI | Director of Finance/CFO | 55 | 2022-04-10 |
Frank Chan
COO | Chief Operating Officer | 56 | 2025-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Kroll
BRD | Director/Board Member | 73 | 2005-12-31 |
| Director/Board Member | 62 | 2016-05-15 | |
Robert Abernathy
BRD | Director/Board Member | 71 | 2017-10-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/24/26 | Free | Director | 2,538 | 0.0056% | ||
| 7/24/26 | Free | Director | 2,538 | 0.0056% | ||
| 7/24/26 | Free | Director | 2,538 | 0.0056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.38% | +0.03% | +136.23% | +30.80% | 5.38B | |
| -0.79% | +4.48% | -19.04% | +8.89% | 181B | |
| -2.09% | +4.85% | -3.14% | +27.61% | 116B | |
| +1.11% | +7.43% | -20.43% | +10.27% | 113B | |
| -1.52% | +3.89% | -51.34% | -7.07% | 79.83B | |
| -0.27% | +4.99% | +4.72% | +79.37% | 65.06B | |
| -0.27% | +2.10% | +15.54% | +66.81% | 54.35B | |
| -0.53% | +3.80% | +0.87% | -26.47% | 52.23B | |
| -0.81% | +7.30% | -12.53% | +30.68% | 44.15B | |
| -0.07% | +2.22% | +29.10% | +2.21% | 32.47B | |
| Average | -0.55% | +4.63% | +8.00% | +22.31% | 74.4B | |
| Weighted average by Cap. | -0.81% | +5.46% | -10.63% | +19.38% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 1.42B 1.26B 1.17B 1.06B 2B 134B 2.03B 14.04B 5.52B 70.23B 5.32B 5.2B 225B | 1.5B 1.33B 1.24B 1.12B 2.11B 142B 2.14B 14.82B 5.82B 74.12B 5.61B 5.49B 237B |
| Net income | 177M 158M 147M 133M 250M 16.84B 254M 1.76B 691M 8.79B 666M 652M 28.13B | 207M 185M 171M 156M 292M 19.67B 297M 2.05B 807M 10.27B 778M 761M 32.86B |
| Net Debt | 662M 590M 547M 498M 934M 62.84B 948M 6.56B 2.58B 32.82B 2.48B 2.43B 105B | 327M 292M 270M 246M 461M 31.05B 469M 3.24B 1.27B 16.22B 1.23B 1.2B 51.86B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-19 | $118.73 | +0.38% | 388,828 |
| 26-10-16 | $118.28 | -2.48% | 471,521 |
| 26-10-15 | $121.29 | +0.15% | 747,647 |
| 26-10-14 | $121.11 | -0.50% | 592,144 |
| 26-10-13 | $121.72 | -0.28% | 829,194 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HAE Stock
Select your edition
All financial news and data tailored to specific country editions
